Matching trials
9 results
- ATLANTICIndependent statistical analysis of ATLANTIC (NCT01347580), a randomized phase 4 trial comparing pre-hospital versus in-hospital initiation of ticagrelor in STEMI patients planned for PCI.
- CARMELINAIndependent statistical analysis of CARMELINA (NCT01897532), a randomized phase 4 trial of linagliptin versus placebo in patients with type 2 diabetes mellitus, including time-to-event methodology, non-inferiority testing, cardiovascular and renal endpoints, safety,…
- COMPASS-2Independent statistical analysis of COMPASS-2, evaluating bosentan added to sildenafil versus sildenafil monotherapy in pulmonary arterial hypertension, including time-to-event, functional, biomarker, quality-of-life, and safety results.
- CRYSTAL-AFIndependent statistical analysis of CRYSTAL-AF, evaluating continuous cardiac monitoring with an insertable cardiac monitor for atrial fibrillation detection after cryptogenic stroke or transient ischemic attack.
- ISCHEMIA-CKDIndependent statistical analysis of ISCHEMIA-CKD, a randomized phase 4 trial comparing invasive and conservative strategies in patients with cardiovascular and kidney disease. Includes trial design, time-to-event endpoints, hazard-ratio interpretation, reported results, safety,…
- PIONEER-HFIndependent statistical analysis of PIONEER-HF, evaluating sacubitril/valsartan versus enalapril on NT-proBNP in patients stabilized after an acute heart failure episode. Includes trial design, ANCOVA methodology, reported primary and secondary results, safety, and…
- PRoFESSAn independent statistical analysis of PRoFESS (NCT00153062), including its randomized double-blind design, recurrent-stroke endpoints, Cox proportional-hazards analyses, non-inferiority framework, hazard ratios, confidence intervals, and secondary outcomes.
- REACTComplete statistical analysis of the REACT trial (NCT01329029), evaluating roflumilast versus placebo in patients with chronic obstructive pulmonary disease treated with fixed LABA and inhaled glucocorticosteroid combinations.
- TRANSITIONIndependent statistical analysis of the TRANSITION phase 4 trial comparing pre- and post-discharge initiation of LCZ696 in patients with heart failure with reduced ejection fraction after an acute decompensation event.